Clinical Study
Outcomes of Neonatal Candidiasis: The Impact of Delayed Initiation of Antifungal Therapy
Table 3
Origin of positive culture specimen: comparison between mortality and survivor groups.
| Culture site | Nonsurvivors (%) | Survivors (%) | value |
| Blood (only isolate) | 3 (17) | 9 (50) | 0.52 | Blood (single or multiple isolates) | 9 (50) | 15 (45) | 0.79 | Tracheal aspiration (only) | 4 (18) | 8 (20) | 1.0 | Urine catheterization (only) | 2 (11) | 9 (27) | 0.30 | Peritoneal or pleural fluid (only) | 2 (11) | 3 (17) | 1.0 | 2 or more positive sites | 11 (61) | 12 (36) | 0.17 |
|
|